CLINICAL_TRIALS
trial_result
· 2021-01-27
Clinical Trial Update: Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006) [Phase 2]
Summary
Multicenter Phase II study of apatinib in advanced breast cancer has completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University Cancer Hospital & Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-01-27